Courtney Wallace - Dec 9, 2021 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
Dec 9, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 04:47 PM
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (right to buy) Award $0 +52K $0.00 52K Dec 9, 2021 Common Stock 52K $13.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36th) of the shares shall vest on a monthly basis following the vesting commencement date of December 9, 2021, subject to the Reporting Person continuing to provide service through each such date.